Archives of Neurology · 1973 · 13 citations · 5 references
Life SciencesImmunologyPharmacologyClinical ImmunologyImmunopathologyImmunoregulationAutoimmune DiseasesAutoimmune RegulationCell-mediated ImmunityImmune SuppressionImmunosuppressionMyasthenia GravisImmune Cell DepletionLymphocyte-depleting AgentsMyasthenia Gravis PharmacotherapyT-cell Mediated Immunity
Thoracic duct lymphocyte depletion, a technique that selectively suppresses cellular immune defenses, was performed in a patient with myasthenia gravis. The patient demonstrated a 70% reduction in anticholinesterase medication requirement. These data lend further support to the apparent relationship between myasthenia gravis, the thymus, and cell-mediated immunity and implicate the lymphocyte, or a substance bound to it, as a contributing factor in myasthenia gravis.
5
Vincent P. Perlo, David C. Poskanzer, Robert S. Schwab et al. · Neurology · 1966 · 201 citations
Life Sciences, Immunology, Neurology +17
The Effect of Thoracic Duct Lymph Drainage in Myasthenia gravis
Kurt Bergström, C Franksson, G. Matell et al. · European Neurology · 2008 · 46 citations
Studies in myasthenia gravis: biologic aspects.
A H Rule, Peter Kornfeld · PubMed · 1972 · 17 citations